These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1011 related articles for article (PubMed ID: 18460980)
1. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980 [TBL] [Abstract][Full Text] [Related]
2. Significance of central perivenulitis in pediatric liver transplantation. Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942 [TBL] [Abstract][Full Text] [Related]
3. All liver recipients benefit from the protocol 10-year liver biopsies. Sebagh M; Rifai K; Féray C; Yilmaz F; Falissard B; Roche B; Bismuth H; Samuel D; Reynès M Hepatology; 2003 Jun; 37(6):1293-301. PubMed ID: 12774007 [TBL] [Abstract][Full Text] [Related]
4. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088 [TBL] [Abstract][Full Text] [Related]
5. Graft and systemic disease in long-term survivors of liver transplantation. Slapak GI; Saxena R; Portmann B; Gane E; Devlin J; Calne R; Williams R Hepatology; 1997 Jan; 25(1):195-202. PubMed ID: 8985290 [TBL] [Abstract][Full Text] [Related]
6. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis in common variable immunodeficiency. Daniels JA; Torbenson M; Vivekanandan P; Anders RA; Boitnott JK Hum Pathol; 2009 Apr; 40(4):484-8. PubMed ID: 19084266 [TBL] [Abstract][Full Text] [Related]
8. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C. Souza P; Prihoda TJ; Hoyumpa AM; Sharkey FE Hum Pathol; 2009 Jan; 40(1):92-7. PubMed ID: 18790517 [TBL] [Abstract][Full Text] [Related]
9. Progressive histological damage in liver allografts following pediatric liver transplantation. Evans HM; Kelly DA; McKiernan PJ; Hübscher S Hepatology; 2006 May; 43(5):1109-17. PubMed ID: 16628633 [TBL] [Abstract][Full Text] [Related]
11. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [TBL] [Abstract][Full Text] [Related]
12. Natural history of unexplained chronic hepatitis after liver transplantation. Syn WK; Nightingale P; Gunson B; Hubscher SG; Neuberger JM Liver Transpl; 2007 Jul; 13(7):984-9. PubMed ID: 17520743 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Shiffman ML; Contos MJ; Luketic VA; Sanyal AJ; Purdum PP; Mills AS; Fisher RA; Posner MP Transplantation; 1994 Feb; 57(4):526-32. PubMed ID: 8116036 [TBL] [Abstract][Full Text] [Related]
14. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038 [TBL] [Abstract][Full Text] [Related]
15. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846 [TBL] [Abstract][Full Text] [Related]
16. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298 [TBL] [Abstract][Full Text] [Related]
17. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621 [TBL] [Abstract][Full Text] [Related]
18. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Saxena R; Crawford JM; Navarro VJ; Friedman AL; Robert ME Mod Pathol; 2002 Sep; 15(9):897-903. PubMed ID: 12218206 [TBL] [Abstract][Full Text] [Related]
19. Late protocol liver biopsies in the liver allograft: a neglected investigation? Mells G; Mann C; Hubscher S; Neuberger J Liver Transpl; 2009 Aug; 15(8):931-8. PubMed ID: 19642126 [TBL] [Abstract][Full Text] [Related]
20. Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations. Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska-Jedynak U; Bogdańska M; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A Transplant Proc; 2006; 38(1):226-30. PubMed ID: 16504709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]